Skip to content
UE PROJECT
Science · Expertise

FENACTIVE®

Scientifically validated antiviral activity against influenza and coronavirus

Science Validation

Inhibition of influenza A virus and human betacoronavirus replication by polyphenol-rich extract blend

Study description:

In vitro study evaluating antiviral activity of a double-standardized blend of aronia and elderberry extracts against human respiratory viruses, including influenza A (H1N1) and betacoronavirus (HCoV-OC43).

Key results:

  • Up to 80% inhibition of influenza A (H1N1) replication
  • ~50% inhibition of human betacoronavirus (HCoV-OC43)
  • Stronger antiviral effect of the blend vs individual extracts
  • Confirmed activity in post-infection phase

Publication status:

Published – In vitro study (Pharmaceuticals, 2022) Download study
Download the full FENACTIVE® brochure

Download the full FENACTIVE® brochure

Full specifications, standardization data, and clinical study documentation in one file.

Download brochure
CUSTOM FORMULATIONS

Looking for scientific documentation?

Our R&D team builds custom extracts, branded actives, and bespoke formulations from over 60 botanical sources. Tell us what you’re working on.

Contact